GlassScriptPhysician profile
Mary Leemputte
NPI 1043673320
$7,792.71
in general payments reported to CMS, 2019-2025
16 companies · $3,260 in 2025
The $3,260 reported for 2025 was more than what 86% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $915 · 2021: $2,383 · 2022: $12.63 · 2023: $585 · 2024: $637 · 2025: $3,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,136 · Food and Beverage: $1,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,136.16 |
| Food and Beverage | $1,346.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,013.93 | 2021-2025 | Proclaim |
| Boston Scientific Corporation | $2,728.57 | 2020-2025 | General - Pain Management, Intracept, Clinical Trial Product |
| Medtronic, INC. | $753.44 | 2021-2024 | Intellis Adaptivestim |
| Curonix LLC | $464.98 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $282.80 | 2020-2025 | Sprint Pns System |
| Nevro Corp. | $206.11 | 2020-2024 | Senza |
| Globus Medical, INC. | $79.50 | 2025 | Senza |
| Stryker Corporation | $63.63 | 2025 | Spinejack |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.68 | 2021 | |
| Medtronic USA, INC. | $35.00 | 2020 | |
| Mml US, INC. | $25.85 | 2025 | Reactiv8 |
| Pacira Pharmaceuticals Incorporated | $19.41 | 2023 | Exparel, Zilretta |
| Biodelivery Sciences International, INC. | $19.34 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.03 | 2025 | |
| Collegium Pharmaceutical, INC. | $15.37 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $14.07 | 2023 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Leemputte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.